Radiation plus hormone therapy may slow resistant prostate cancer
Disease control
Recruiting now
This study tests whether adding precise, high-dose radiation (SBRT) to standard second-generation antiandrogen drugs (enzalutamide or abiraterone) can better control prostate cancer that has spread to a few spots and stopped responding to hormone therapy. About 51 men with oligom…
Phase: PHASE2 • Sponsor: Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC